ATXN3 and Machado-Joseph disease: Finally, our observation that elevated plasma polyQ-ATXN3 levels correlated with measures of cerebellar degeneration and locomotion in 6-month-old mice supports the use of our polyQ-ATXN3 immunoassay as a biomarker in SCA3.